Sanofi is recruiting a Global Medical Lead for Type 1 diabetes in the Insulin team. The Global Medical Lead will report directly to the Global Medical Head of Insulins, General Medicines GBU
The role functions internally as the expert of type 1 diabetes to lead the medical affairs activities and execution of the franchise and product strategies as integrated in global medical plan
Essential to success is productive partnership with Commercial, Market Access and Digital Health Care and other cross-functional teams to maximize the value proposition of assets related to Type 1 diabetes
Externally, collaboration and support of health care professionals, people with type 1 diabetes and their associations and payers are key to optimize care and treatment outcomes through evidence-based decisions
KEY ACCOUNTABILITIES
Leading Global Type 1 diabetes medical activities and projects and act as a medical lead in cross-functional projects
Developing and executing a highly efficient, global medical affairs/scientific plan as part of the integrated franchise/product plan(s) with all key stakeholders in close collaboration with key countries (‘glocal’ approach)
Searching for and evaluate innovating opportunities within the type 1 diabetes to enhance the value of diabetes portfolio
Partner with key stakeholders to utilize the opportunities from digital health care for patients with type 1 diabetes
Reviewing and approving medical and scientific content of materials for Regulatory, Safety, Scientific Communication, Medical Affairs, and Commercial purposes
Providing leadership and strategic directions to the country medical teams in interactions and communications with external customers, key organizations, and institutions
Ensuring key market country and regions perspectives and local insights are captured when developing the global strategy and activities for type 1 diabetes as applicable
Pro-actively providing guidance to global marketing team including insights, recent developments and competitor activities and treatment practices and guidelines in type 1 diabetes
Interacting with experts at medical meetings, advisory boards, and face-to-face interactions and maintain and strengthen Sanofi reputation in insulin field
PROFILE
Education/professional experience
Medical degree
Prior experience in type 1 diabetes is an advantage
Industry experience in Medical Affairs/R&D >5 years
Sound scientific and clinical judgment, including in-depth understanding of development, the scientific methods and clinical applications based on medical, scientific, and practical rationale
Excellent skills working with experts from other functions and countries and influencing decision making
An absolute commitment to ethical standards and compliance
Ability to understand and effectively communicate scientific and medical data results and information to internal and external stakeholders
Excellent communication skills with the ability to build solid working relationships with the cross-functional teams
Other qualities
Strong interpersonal skills with the ability to collaborate with others
A team player; able to collaborate successfully with both internal and external colleagues
Excellent communication skills both written and oral English
Committed to ethics and scientific standards
Commitment to Sanofi culture
Strong analytical skills, comfort managing through ambiguity
Understanding and success in dealing with different cultures and diversity
Ability to manage competing priorities and projects, requiring an excellent ability to prioritize and manage expectations
A spirit to consistently seek opportunities to learn more and develop
Please provide your resume in PDF format
This is our Sanofi, Discover yours !
Cambridge, MA
As the specialty care global business unit of Sanofi, we are focused on rare diseases, rare blood disorders, multiple sclerosis, oncology and immunology. More than 30 years since we began, we remain just as committed to and passionate about advancing therapies that offer hope to patients and families.
Our approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, we rapidly grew to become one of the world’s leading biotechnology companies, recognized for our pioneering development of treatments for rare genetic disorders and our innovative contributions to medical science and biomanufacturing.
Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, we also established ourselves as a leader in the field of multiple sclerosis. In 2016, our focus expanded to include Sanofi’s programs in oncology and immunology. In 2018, with the acquisitions of Bioverativ and Ablynx, we further expanded our focus to include rare blood disorders, bringing deep expertise in hematology.
Our ambition is to be the industry leader in specialty care. We currently provide more than 25 treatments to patients globally, with many potential new therapies being studied in clinical trials and in Sanofi laboratories.
Driven by our commitment to patients, we strive to develop strong relationships with our patient communities, listening to their perspectives so that we can truly understand their needs. These collaborations continue to guide and motivate us as we work to push the boundaries of medicine and technology to develop new and better therapies where none existed before.